Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-225,000
Closed -$2.84M 20
2017
Q4
$2.84M Sell
225,000
-475,000
-68% -$5.09M 1.74% 12
2017
Q3
$6.79M Sell
700,000
-507,800
-42% -$4.34M 3.19% 14
2017
Q2
$9.31M Buy
1,207,800
+82,800
+7% +$555K 4.96% 8
2017
Q1
$7.95M Sell
1,125,000
-775,000
-41% -$5.38M 2.83% 12
2016
Q4
$13M Sell
1,900,000
-75,000
-4% -$582K 3.98% 9
2016
Q3
$16.4M Buy
1,975,000
+75,000
+4% +$719K 2.57% 14
2016
Q2
$21.4M Hold
1,900,000
3.53% 12
2016
Q1
$18.3M Buy
1,900,000
+325,000
+21% +$3.02M 2.5% 17
2015
Q4
$16.1M Buy
1,575,000
+527,812
+50% +$5.68M 1.9% 16
2015
Q3
$13.5M Hold
1,047,188
1.33% 22
2015
Q2
$15.4M Sell
1,047,188
-249,203
-19% -$3.52M 1.51% 21
2015
Q1
$15.3M Buy
+1,296,391
New +$14.5M 1.68% 17

Other funds holding CROX

North Run Capital's CROX Position: Q1 2018 in Review

North Run Capital sold out of Crocs (CROX) in Q1 2018, closing a stake of 225,000 shares — an estimated $2.84M sold.

North Run Capital first reported a position in CROX in Q1 2015 and held it in 12 quarters. The position peaked at $21.4M in Q2 2016. 193 funds tracked by Wall St. Rank hold CROX as of Q1 2018.

  • North Run Capital reported no remaining Crocs position as of Q1 2018 after selling out during the quarter.
  • North Run Capital sold 225,000 Crocs shares in Q1 2018, an estimated $2.84M.
  • North Run Capital first reported a position in Crocs in Q1 2015 and held it in 12 quarters.
  • North Run Capital's Crocs position peaked at $21.4M in Q2 2016.
  • 193 funds tracked by Wall St. Rank held Crocs as of Q1 2018.

Based on North Run Capital's 13F filing for Q1 2018, filed 11 May 2018.